# The Human Medicines Regulations 2012, Paragraph 3

Extent: E+W+S+N.I.

The following medicinal products shall be available only from a pharmacy—
(a) a product comprising eye ointment;
(b) a product that contains Vitamin A, Vitamin A acetate or Vitamin A palmitate, in each case with a maximum daily dose equivalent to more than 7500 international units of Vitamin A or 2250 micrograms of retinol;
(c) a product that contains Vitamin D with a maximum daily dose of more than 400 units of antirachitic activity ; ...
(d) a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, it is only to be available from a pharmacy ; and
(e) an EAMS medicinal product, in circumstances where the licensing authority has attached a condition to the EAMS scientific opinion in respect of that product to the effect that, for the duration of that opinion, it is only to be available from a pharmacy.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/1/paragraph/3 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-1/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.